Massachusetts 2025-2026 Regular Session

Massachusetts Senate Bill S1406 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	1 of 1
2	2	SENATE DOCKET, NO. 962 FILED ON: 1/15/2025
3	3	SENATE . . . . . . . . . . . . . . No. 1406
4	4	The Commonwealth of Massachusetts
5	5	_________________
6	6	PRESENTED BY:
7	7	John F. Keenan
8	8	_________________
9	9	To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
10	10	Court assembled:
11	11	The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
12	12	An Act relative to the prescription monitoring program.
13	13	_______________
14	14	PETITION OF:
15	15	NAME:DISTRICT/ADDRESS :John F. KeenanNorfolk and PlymouthJames K. Hawkins2nd Bristol2/11/2025 1 of 2
16	16	SENATE DOCKET, NO. 962 FILED ON: 1/15/2025
17	17	SENATE . . . . . . . . . . . . . . No. 1406
18	18	By Mr. Keenan, a petition (accompanied by bill, Senate, No. 1406) of John F. Keenan and James
19	19	K. Hawkins for legislation relative to the prescription monitor program. Mental Health,
20	20	Substance Use and Recovery.
21	21	The Commonwealth of Massachusetts
22	22	_______________
23	23	In the One Hundred and Ninety-Fourth General Court
24	24	(2025-2026)
25	25	_______________
26	26	An Act relative to the prescription monitoring program.
27	27	Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
28	28	of the same, as follows:
29	29	1 SECTION 1. Section 24A of Chapter 94C of the General Laws, as appearing in the 2022
30	30	2Official Edition, is hereby amended by inserting after subsection (c) the following new
31	31	3subsection:-
32	32	4 (c½) The department shall establish, by rule or regulation, a process by which to include
33	33	5information about the administration of opioid maintenance treatment in the prescription
34	34	6monitoring program, when the inclusion of such information does not conflict with state or
35	35	7federal privacy rules. The purpose of this subsection shall be to ensure that licensed professionals
36	36	8authorized to prescribe controlled substances receive information, through utilization of the
37	37	9prescription monitoring program, about an individual patient’s participation in opioid
38	38	10maintenance treatment prior to issuing a new prescription for an opioid substance other than the
39	39	11substance used for opioid maintenance treatment. 2 of 2
40	40	12 SECTION 2. Section 18 of chapter 111E of the General Laws, is hereby amended by
41	41	13inserting after subsection (a) the following new subsection:-
42	42	14 (a½) For each facility that is an opioid treatment program, as defined under 42 CFR Part
43	43	158, the facility shall present to each individual entering treatment a form that allows the individual
44	44	16to consent to the release of information, through the prescription monitoring program, about the
45	45	17administration of opioid maintenance treatment at the facility. Said consent form shall be
46	46	18accompanied by information clearly explaining that such consent is not required but is
47	47	19encouraged to improve coordination of services; and by information on how the individual may
48	48	20complete and return the form to the facility or to the department of public health if they elect to
49	49	21give such consent. A record of the individual’s election relative to this form shall be maintained
50	50	22by the facility as part of the record of treatment required by this section. The same form and
51	51	23information shall be presented to the individual upon their discharge from the facility.